Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers
Open Access
- 1 November 1987
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (11) , 1665-1668
- https://doi.org/10.1128/aac.31.11.1665
Abstract
Pefloxacin, a new fluoroquinolone, was given to 10 volunteers in single 400-mg oral doses repeated at 12-h intervals during 7 days. Serum, saliva, and feces samples were collected before and at appropriate intervals after the initiation of treatment. Drug concentrations were determined by bioassay. Qualitative and quantitative analyses of the saliva and fecal floras were performed. Mean concentrations in saliva (3.46 micrograms/ml on day 1 and 7.54 micrograms/ml on day 7) were closely related to levels in serum. High concentrations of pefloxacin were found in the feces (645 micrograms/g on day 8). No modification of oral flora was observed. In the fecal flora, members of the family Enterobacteriaceae were eliminated between days 2 and 8. The alterations in streptococci and anaerobic flora were not significant; Bacteroides fragilis was more resistant to pefloxacin after treatment. Clostridium difficile was not detected, and there was no overgrowth by yeasts. No side effects were observed.Keywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteersJournal of Antimicrobial Chemotherapy, 1986
- Impact of oral ciprofloxacin on the faecal flora of healthy volunteersInfection, 1985
- Ciprofloxacin for Selective Decontamination of the Alimentary Tract in Patients with Acute Leukemia During Remission Induction Treatment: The Effect on Fecal FloraThe Journal of Infectious Diseases, 1985
- In-vitro activity of pefloxacin compared to enoxacin, norfioxacin, gentamicin and newβ-lactamsJournal of Antimicrobial Chemotherapy, 1985
- The Microbial Flora of the Rectal Mucosa and Faeces of Patients with Crohn's Disease Before and During Antimicrobial ChemotherapyJournal of Medical Microbiology, 1984
- In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867)Antimicrobial Agents and Chemotherapy, 1984
- Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteersAntimicrobial Agents and Chemotherapy, 1984
- Recovery of norfloxacin in feces after administration of a single oral dose to human volunteersAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivativesAntimicrobial Agents and Chemotherapy, 1984
- Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humansAntimicrobial Agents and Chemotherapy, 1984